Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2002 Oct;11(5):329–331. doi: 10.1080/09629350210000015755

Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines.

Ibtissam Youlyouz 1, Emmanuelle Magnoux 1, Laurence Guglielmi 1, Yves Denizot 1
PMCID: PMC1781672  PMID: 12467527

Abstract

Platelet-activating factor receptor (PAF-R) transcripts were analysed by reverse transcriptase-polymerase chain reaction in five human cancer cell lines derived from the breast (BT20, SKBR3 and T47D cells), the pancreas (Miapaca cells) and the bladder (5,637 cells) in order to confirm the existence of a splice variant of the PAF-R transcript 2. After cloning and sequencing, we confirmed its existence in all cell lines. It consisted of the PAF-R transcript 2 lengthening with 82 nucleotides from the 3' end of exon 1 of the PAF-R gene. The role of this elongated form of the tissue-type PAF-R transcript in cell physiology remains to be elucidated.

Full Text

The Full Text of this article is available as a PDF (217.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desplat V., Besse A., Faucher J. L., Praloran V., Denizot Y. Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells. Stem Cells. 1999;17(2):121–124. doi: 10.1002/stem.170121. [DOI] [PubMed] [Google Scholar]
  2. Desplat V., Dulery C., Faucher J. L., Praloran V., Denizot Y. Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. Cancer Lett. 2000 Feb 28;149(1-2):7–13. doi: 10.1016/s0304-3835(99)00295-5. [DOI] [PubMed] [Google Scholar]
  3. Ishii S., Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res. 2000 Jan;39(1):41–82. doi: 10.1016/s0163-7827(99)00016-8. [DOI] [PubMed] [Google Scholar]
  4. Kotelevets L., Noë V., Bruyneel E., Myssiakine E., Chastre E., Mareel M., Gespach C. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion. J Biol Chem. 1998 Jun 5;273(23):14138–14145. doi: 10.1074/jbc.273.23.14138. [DOI] [PubMed] [Google Scholar]
  5. Mutoh H., Bito H., Minami M., Nakamura M., Honda Z., Izumi T., Nakata R., Kurachi Y., Terano A., Shimizu T. Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. FEBS Lett. 1993 May 10;322(2):129–134. doi: 10.1016/0014-5793(93)81552-b. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES